The European Laboratory Analysis & Innovation Group (ELRIG) UK right this moment introduced the keynote audio system for Drug Discovery 2023, going down on the ACC in Liverpool from 18–19 October. Prof Janet Hemingway CBE, FRS, Founding Director of An infection Innovation Consortium (iiCON), and Dr Dave Powell, Chief Scientific Officer (CSO) of LifeArc will lead this 12 months’s occasion focussing on various considering and new views.
The group’s free-to-attend, flagship convention will cowl a variety of themes from ‘omics, and personalised drugs to chemistry; all targeted on bringing new therapies from the lab to the affected person.
Janet Hemingway is Professor of Tropical Drugs on the Liverpool College of Tropical Drugs (LSTM) and the Founding Director of iiCON, a collaborative £230 million programme bringing collectively educational, trade and medical companions to assist remodel the invention and provide of anti-infectives and speed up their journey to market. She is a senior technical advisor on Uncared for Tropical Illnesses for the Invoice and Melinda Gates Basis and has been PI on initiatives in extra of £370 million. Prof Hemingway was Director of LSTM from 2001 to 2019 and she or he was awarded a CBE for companies to the Management of Tropical Illness Vectors in 2012.
Dave Powell joined LifeArc as CSO in 2022 as the subsequent step in his 25 years in R&D. Previous to this he led the preclinical drug discovery and the part lll antibiotic analysis programme at Summit Therapeutics. Dr Powell started his life sciences profession at SmithKline Beecham (now GSK), gaining deep platform and undertaking expertise throughout quite a few therapeutic areas, together with neurosciences, oncology, and infectious illness. He additionally helped to begin after which led the collaboration between GSK and the Francis Crick Institute in London.
Drug Discovery 2023 will embody displays from leaders of their fields, a commerce present and exhibition, a poster competitors, tech theatres focussed on robotics and automation, and sustainability practices, a bunch of networking alternatives and a studying zone for early profession professionals.
The convention will run 4 parallel classes every day focussed on: mobile applied sciences for drug discovery, reworking most cancers drug discovery by way of various considering and improvements, delving into the range of chemistry, driving molecules from idea to clinic, augmenting R&D with AI, biopharmaceutical discovery, translating concepts into therapies, hit identification and screening, and chemistry enabling drug discovery from begin to clinic.
Sanj Kumar, CEO, ELRIG UK stated: “ELRIG is devoted to delivering nice scientific content material with variety and inclusivity in-built, and the calibre of talks at this 12 months’s occasion are testomony to that. The keynote audio system are such influential and extremely revered scientists of their respective fields. We’re delighted to have them lead the scientific programme at Drug Discovery 2023 and assist us in driving collaboration throughout the scientific neighborhood as we proceed to develop our various community.”
Prof Janet Hemingway, Founding Director, iiCON stated: “It’s an honour to be presenting at this 12 months’s Drug Discovery occasion in Liverpool. I stay up for connecting with thought leaders, sharing insights, and gaining new views on key areas of significance within the area and future instructions for novel therapeutics.”
Dr Dave Powell, CSO, LifeArc stated: “I’m keen about discovery innovation but additionally about how we are able to practice and put together the subsequent technology of drug discovery scientists. So, I’m proud to be presenting at ELRIG’s flagship occasion this 12 months the place new concepts and expertise are all the time to the fore, however importantly ELRIG Drug Discovery is a extremely approachable convention for our youthful colleagues as properly.”
For a full itemizing of audio system and classes, to register or guide an exhibition stand, please go to:
